Chemed Corp
NYSE:CHE

Watchlist Manager
Chemed Corp Logo
Chemed Corp
NYSE:CHE
Watchlist
Price: 570.96 USD 1.36% Market Closed
Market Cap: 8.6B USD
Have any thoughts about
Chemed Corp?
Write Note

Operating Margin
Chemed Corp

16.9%
Current
16%
Average
4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
16.9%
=
Operating Profit
401.2m
/
Revenue
2.4B

Operating Margin Across Competitors

Country US
Market Cap 8.6B USD
Operating Margin
17%
Country US
Market Cap 91.8B USD
Operating Margin
4%
Country US
Market Cap 87.7B EUR
Operating Margin
4%
Country US
Market Cap 73B USD
Operating Margin
3%
Country DE
Market Cap 24.9B EUR
Operating Margin
7%
Country US
Market Cap 20.1B USD
Operating Margin
9%
Country DE
Market Cap 18.8B EUR
Operating Margin
7%
Country US
Market Cap 18.3B USD
Operating Margin
14%
Country US
Market Cap 13.7B USD
Operating Margin
15%
Country DE
Market Cap 12.4B EUR
Operating Margin
7%
Country AU
Market Cap 13.4B AUD
Operating Margin
9%
No Stocks Found

Chemed Corp
Glance View

Market Cap
8.6B USD
Industry
Health Care

Chemed Corp. is a distinguished player in the healthcare sector, known primarily for its two main subsidiaries: VITAS Healthcare and Chemed Home Health. VITAS is the nation’s leading provider of hospice and palliative care services, which cater to patients with life-limiting illnesses. This segment underscores Chemed’s dedication to enhancing the quality of life for patients and their families, focusing on compassionate care and support during critical times. Operating in a market increasingly underpinned by an aging population and a growing preference for home-based healthcare solutions, Chemed stands to benefit from favorable demographic trends. In addition, its Chemed Home Health division positions the company well within the rapidly expanding home healthcare market, facilitating personalized care in a familiar environment, which has shown significant promise in improving patient outcomes. For investors, Chemed Corp. offers a compelling investment narrative characterized by steady growth, financial stability, and a robust operational model. The company has demonstrated strong revenue generation and consistently high margins, reflective of its effective management and operational efficiencies. With a solid balance sheet and commitment to shareholder returns, Chemed has a track record of delivering value through dividends and strategic reinvestments. Moreover, as healthcare policies increasingly favor in-home care solutions and as demographics shift towards an older population, Chemed is poised to capture considerable market opportunities. Its proven ability to adapt to changing healthcare needs not only underlines its resilience but also highlights its potential for sustained financial performance and long-term growth.

CHE Intrinsic Value
503.31 USD
Overvaluation 12%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
16.9%
=
Operating Profit
401.2m
/
Revenue
2.4B
What is the Operating Margin of Chemed Corp?

Based on Chemed Corp's most recent financial statements, the company has Operating Margin of 16.9%.